Kim Kamdar, Ph.D.

Kim Kamdar, Ph.D.

Chair of the BoardatSera Prognostics· In proxies 2023–2025

Kim Kamdar, Ph.D. sits on 8 public boards.

Boards1

  • Sera PrognosticsChair · 13 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Sera PrognosticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role +50%
  2. Alume BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  3. Evofem Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Pleno, IncPublic company
    • Director? – PresentNo stock prices for these years
  5. Seraphina TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  6. Seraphina Therapeutics andPublic company
    • Director? – PresentNo stock prices for these years
  7. Singular Genomics SystemsPublic company
    • Director? – PresentNo stock prices for these years
  8. Truvian Sciences, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?